Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 4 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of HAS3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 1830.10 | 21 / 21 | 81% | 72.78 | 410 / 504 |
uterus | 96% | 248.22 | 163 / 170 | 64% | 48.13 | 292 / 459 |
lung | 85% | 630.98 | 492 / 578 | 74% | 70.03 | 851 / 1155 |
thymus | 100% | 1241.10 | 650 / 653 | 59% | 10.72 | 354 / 605 |
esophagus | 77% | 2114.20 | 1116 / 1445 | 72% | 66.17 | 132 / 183 |
intestine | 78% | 338.07 | 752 / 966 | 53% | 10.57 | 277 / 527 |
stomach | 74% | 721.56 | 267 / 359 | 42% | 8.14 | 120 / 286 |
prostate | 96% | 715.93 | 236 / 245 | 9% | 1.42 | 46 / 502 |
breast | 86% | 1550.46 | 396 / 459 | 17% | 3.07 | 191 / 1118 |
ovary | 97% | 266.08 | 175 / 180 | 5% | 0.47 | 20 / 430 |
ureter | 0% | 0 | 0 / 0 | 100% | 67.68 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 89% | 76.30 | 40 / 45 |
pancreas | 47% | 99.62 | 154 / 328 | 42% | 15.19 | 74 / 178 |
skin | 76% | 974.13 | 1374 / 1809 | 10% | 2.13 | 48 / 472 |
spleen | 80% | 143.50 | 194 / 241 | 0% | 0 | 0 / 0 |
adipose | 67% | 145.35 | 811 / 1204 | 0% | 0 | 0 / 0 |
kidney | 60% | 161.65 | 53 / 89 | 8% | 1.19 | 69 / 901 |
brain | 54% | 128.92 | 1418 / 2642 | 7% | 0.89 | 48 / 705 |
liver | 45% | 94.85 | 102 / 226 | 3% | 0.52 | 12 / 406 |
blood vessel | 39% | 70.16 | 520 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 31% | 47.20 | 80 / 258 | 1% | 0.37 | 3 / 230 |
muscle | 18% | 30.26 | 143 / 803 | 0% | 0 | 0 / 0 |
heart | 14% | 22.67 | 121 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 4.01 | 11 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0030213 | Biological process | hyaluronan biosynthetic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_1900106 | Biological process | positive regulation of hyaluranon cable assembly |
GO_0045226 | Biological process | extracellular polysaccharide biosynthetic process |
GO_0085029 | Biological process | extracellular matrix assembly |
GO_0036117 | Cellular component | hyaluranon cable |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005769 | Cellular component | early endosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005634 | Cellular component | nucleus |
GO_0050501 | Molecular function | hyaluronan synthase activity |
GO_0005515 | Molecular function | protein binding |
GO_0042802 | Molecular function | identical protein binding |
Gene name | HAS3 |
Protein name | Hyaluronan synthase 3 (EC 2.4.1.212) (Hyaluronate synthase 3) (Hyaluronic acid synthase 3) (HA synthase 3) Hyaluronan synthase 3 variant 1 (Hyaluronan synthase 3 variant 2) hyaluronan synthase (EC 2.4.1.212) |
Synonyms | |
Description | FUNCTION: Catalyzes the addition of GlcNAc or GlcUA monosaccharides to the nascent hyaluronan polymer. Therefore, it is essential to hyaluronan synthesis a major component of most extracellular matrices that has a structural role in tissues architectures and regulates cell adhesion, migration and differentiation. This is one of three isoenzymes responsible for cellular hyaluronan synthesis. . |
Accessions | Q96RV2 ENST00000569188.6 [O00219-1] O00219 H3BRH5 C0KZD9 ENST00000219322.7 [O00219-2] ENST00000566118.5 ENST00000306560.1 [O00219-1] |